IL36A

IL36A, also known as Interleukin-36 alpha, is a member of the IL-36 cytokine family, which is part of the broader IL-1 cytokine superfamily. These cytokines play crucial roles in regulating immune responses, particularly in inflammation and host defense. IL36A is primarily expressed by epithelial cells and is involved in initiating and amplifying inflammatory cascades.

This cytokine is synthesized as an inactive precursor that undergoes processing to become biologically active. IL36A exerts its effects by binding to a specific receptor, the IL-36 receptor (IL36R), which is expressed on various immune cells, including T cells, B cells, and myeloid cells. Upon binding, IL36A activates intracellular signaling pathways that lead to the production of other pro-inflammatory cytokines and chemokines.

Dysregulation of IL36A signaling has been implicated in several inflammatory and autoimmune diseases. Mutations in the IL36RN gene, which encodes the IL-36 receptor antagonist (a natural inhibitor of IL-36 signaling), can lead to autoinflammatory conditions such as generalized pustular psoriasis (GPP) and other forms of palmoplantar pustulosis. These conditions are characterized by severe, recurrent inflammation and pustule formation. Research into the specific roles of IL36A in various diseases is ongoing, with a focus on its potential as a therapeutic target for inflammatory disorders.